Department of Pathology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea.
Am J Clin Pathol. 2012 Dec;138(6):846-54. doi: 10.1309/AJCPO46GFKGNXCBR.
The aim of this study was to determine the prognostic effect of the absolute neutrophil count/absolute lymphocyte count ratio (ANC/ALC ratio) in patients with classic Hodgkin lymphoma (cHL). We performed a retrospective analysis of 312 patients with cHL. Univariate analysis revealed that a high ANC/ALC ratio (≥4.3) correlated with poor overall survival (OS) (P < .001). Subgroup analysis of advanced-stage disease showed that the ANC/ALC ratio was significant for OS (P = .032). Multivariate analysis revealed the ANC/ALC ratio to be an independent prognostic factor for OS (P = .048). The ANC/ALC ratio allowed further risk stratification in patients who were considered to be at low risk on the basis of an International Prognostic Score less than 4 (P = .002). The ANC/ALC ratio is a simple, inexpensive, and independent prognostic factor for OS that may improve the ability to identify high-risk patients with cHL.
本研究旨在确定经典霍奇金淋巴瘤(cHL)患者中性粒细胞绝对计数/淋巴细胞绝对计数比值(ANC/ALC 比值)的预后价值。我们对 312 例 cHL 患者进行了回顾性分析。单因素分析显示,高 ANC/ALC 比值(≥4.3)与总生存(OS)不良相关(P<0.001)。晚期疾病亚组分析显示,ANC/ALC 比值对 OS 有意义(P=0.032)。多因素分析显示 ANC/ALC 比值是 OS 的独立预后因素(P=0.048)。ANC/ALC 比值可进一步对国际预后评分(IPS)<4 的低危患者进行风险分层(P=0.002)。ANC/ALC 比值是 OS 的一个简单、经济且独立的预后因素,可能提高识别 cHL 高危患者的能力。